Skip to content
The Nexus
BUSINESSJul 17 · 18:10 UTCWSOC ABC CHARLOTTECharlotte Business Journal

$1B Swiss biotech establishes US headquarters in the Queen City

Swiss biotech company MindMaze Therapeutics has established its U.S. headquarters in Charlotte's The Pearl innovation district. The company, which focuses on neurotherapeutic technology for stroke, Alzheimer disease, and Parkinson disease, opened a Patient Experience Center in May at Connect Labs by Wexford.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
MindMaze TherapeuticsorganizationZach HendersonpersonConnect Labs by WexfordorganizationThe Pearl innovation districtplaceCharlotteplaceLausanneplaceneurotherapeutic technologytopicstroketopicAlzheimer diseasetopicParkinson diseasetopic
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting